78 results
8-K
EX-99.1
BBIO
BridgeBio Pharma Inc
2 May 24
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
7:31am
of the Company’s novel precision oncology pipeline; and the Company’s financial performance, capitalization status, strategy, business plans and goals reflect
424B5
mg59b5dyctoaf1x1yo8
6 Mar 24
Prospectus supplement for primary offering
5:15pm
424B5
1omdwgjf
4 Mar 24
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
2vnr8 r8uwp2qz
22 Feb 24
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
7:31am
8-K
EX-99.1
d3nnjk5uhepdah6ni sh
8 Jan 24
Other Events
5:14pm
S-3ASR
rtbr3
2 Nov 23
Automatic shelf registration
4:59pm
8-K
EX-99.1
haw03y55o6t2k6tnhx
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm
S-3ASR
6zawu
26 Jul 23
Automatic shelf registration
4:06pm
8-K
EX-99.1
pczzyz3hnt 8e
17 Jul 23
Regulation FD Disclosure
7:23am
S-3ASR
6qz yt3242
4 May 23
Automatic shelf registration
4:55pm